| Abstract |
Objective To investigate the effect of patient-controlled epidural labor analgesia on labor and maternal and infant prognosis during labor. Methods The start stage of the study was May 2021, and the end time node was May 2022. The study samples included in this stage were all primiparas who received delivery in the obstetrics and gynecology department of our hospital, with a sample size of 500 cases. After selecting and sorting out the relevant data of the puerperae, a retrospective analysis was carried out. According to whether the puerpera received ropivacaine combined with fentanyl patient-controlled epidural analgesia during delivery, they were divided into groups, namely the analgesia group (receiving patient-controlled epidural delivery, n=167 cases) and the non-analgesic group (not receiving patient-controlled epidural delivery, n=333), the differences in labor process, pain scores, and delivery outcomes for different types of mothers were compared. Results Comparing the VAS scores of puerperae in different stages of labor between the two groups, the analgesic group was lower than the non-analgesic group, with significant differences and statistical significance (P<0.05). Comparing the latent period and active period of the two groups, the non-analgesic group was longer than the analgesic group; the analgesic group was longer than the non-analgesic group in the second stage of labor, with significant differences and statistical significance (P<0.05). Compared with the non-analgesic group, the analgesic group had a higher rate of vaginal delivery (P<0.05). There was no significant difference in the incidence of fetal distress and Apgar score between the two groups (P>0.05). Conclusion The use of self-controlled epidural analgesia in labor is beneficial to improve the rate of vaginal delivery, and the maternal and infant complications will not increase after application. It has high safety and effectiveness, and can be used for reference in labor analgesia.
|